chrisvoncsefalvay/vaers-outcomes huggingface dataset:
FLU-LIKE SYMPTOMS (CHILLS, GENERAL ACHES, HEADACHES); EARS RINGING; BLURRED VISION; This spontaneous report received from a patient concerned a 63 year old female patient of an unspecified race and ethnic origin. The patient's weight was 140 pounds, and height was 66 inches. The patient's concurrent conditions included: penicilline allergy, and also had drug allergy with codeine, and gabapentin.  On an unspecified date, the patient received bnt 162 (Pfizer vaccine), (form of admin, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, ( Dose number in series 1) for prophylactic vaccination.  On an unspecified date, following vaccination with Pfizer vaccine, the patient experienced severe allergic reaction ( Dose number in series 1).   The patient received additional company suspect vaccine covid-19 vaccine ad26.cov2.s, (suspension for injection, route of administration not reported, batch number: 213D21A, expiry: 11-APR-2022) dose was not reported, 01 total, administered on 06-DEC-2021 on left arm ( Dose number in series 2) for prophylactic vaccination. No concomitant medications were reported.  On 06-DEC-2021, the patient experienced blurred vision and ears ringing which came on rather quickly, like within 30 minutes of injection. The patient also stated that the ringing had gone but the blurry vision was still there on 07-DEC-2021. On 07-DEC-2021, the patient experienced flu-like symptoms (chills, general aches, headaches) (Dose number in series 2).  she contacted her health care professional and was referred to an ophthalmologist. On 07-DEC-2021, laboratory data included: Body temperature was 97.1 Fahrenheit showed no fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ears ringing (on unspecified date) in DEC-2021, had not recovered from blurred vision and outcome for flu-like symptoms (chills, general aches, headaches) was unknown. This report was non-serious.
Dizziness upon awakening in  the morning and lasting several hours.  This happened for 4 consecutive days.
Almost uncontrollable shaking, 2.3 degree increase in temperature,  really  bad diarrhea .  Symptoms lasted around 12 hours, temperature came down in a day and I took Tylenol
1st Dose received Friday 1/22/21mild injection site arm pain, arm feels heavy, tired, a little brain fog. Monday 1/25-26 Significant arm pain also in wrist, stomach cramping, diarheaa, brain fog, tired
Pt. presented to clinic 11/19/10 with zoster rash, was diagnosed with herpes zoster and prescribed VALTREX 1g TID x 7 d.
My left arm became itchy and inflamed two days after the shot. This happened to me with the original vaccines, Moderna, but not with the two boosters, also Moderna. This was the Moderna bivalent booster. My last booster was the end of May, about 7 months ago.  I believe this is referred to as the Moderna arm? It's red and itchy, also hurts, similar to what happened with the initial vaccines. I expect it to go away in a week or two, but thought I should report it so that you'll be aware this is still happening to some people who get the Moderna booster.
Shortness of Breath, Weakness, rapid heart rate, and uncontrollable body shakes (severe).  Symptoms lasted approximately 6 hours.
Information has been received from a registered nurse concerning a 13 month old female with no allergies or medical history who on 17-MAY-2007 was vaccinated SC on left thigh with 0.5 ml dose of ProQuad (Lot# 656446/1483F). Concomitant therapy included a dose of DTaP (+) tetanus toxoid, a dose of Vaqta, a dose of Pedvaxhib and a dose of Prevnar. There was no other concomitant medication. On 20-MAY-2007, the patient developed a rash which was described as six inches from the injection site on the left thigh. It was reported that less than 50 lesions were noted. Unspecified medical attention was sought. At the time of report the patient was recovering. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 7/6/2007. Information has been received from a registered nurse concerning a 13 month old female with no allergies or medical history who on 17-MAY-2007 was vaccinated SC on left thigh with the first dose of 0.5 ml dose of MMR II (Merck upgrade process) (Lot #656446/1483F). On 17-MAY-2007, concomitant vaccinations included the second dose of INFANRIX (Lot # AC148036AA) IM in the right thigh, a dose of HEP A (inactive), the second dose of PEDVAXHIB (Lot # 652222/1189R) IM in the right thigh and a second dose of PREVNAR (Lot #B086744) IM in the left thigh. There was no other concomitant medication. On 15-MAY-2007 also reported as 2-3 days following immunization, the patient had an "onset rash in diaper area" which resolvedin 4-5 days (recovery date also reported as 23-MAY-2007). The patient did not require medical care. On 20-MAY-2007, the patient developed a rash which was described as six inches from the injection site on the left thigh. It was reported that less than 50 lesions were noted. Unspecified medical attention was sought. At the time of report the patient was recovering. A product quality complaint was not involved. The patient's mother was expecting a baby and was concerned about chickenpox. Additional information has been requested.
Child's mother reported to me that child had been hospitalized with "ITP". She said the hospital said it may have been caused by MMR vaccine. Child is home recovering.
After 20 min I started feeling flush and heart palpitations, my heart was getting tachy. I also felt nauseous and fatigued. At the ER they took my vitals my BP and heart rate were high. I still every once in a while have increased heart rate (above 100) and every once in a  while I also have muscles twitching.
I went on a camping trip with a friend. We did not test for COVID-19 before taking the trip. It was a 7- or 8-hour drive. My friend and I stayed the night in a hotel during the trip. Sometime during the night, my friend developed symptoms. He tested the next morning and was positive for COVID-19. We drove back in separate vehicles. I alerted my doctor of my exposure to COVID-19. The exposure occurred on 01/30/2023. My very minor symptoms began to show on 02/02/2023. My doctor immediately called in a prescription for PAXLOVID. I had a fever of 101 degrees, but that subsided as soon as I began taking the PAXLOVID. I had a little bit of fatigue and achiness for around 24 hours. The day after my symptoms began, I was able to take my normal neighborhood walk. The last time I had a physical, my kidney function was a little bit off, so I took an altered dosage of PAXLOVID. Before I was done with the five days of PAXLOVID, I was feeling fine and well enough to hike. Three days later, I had a slight fever return and was still testing positive. I called my doctor who advised that I take another round of PAXLOVID. My symptoms improved almost immediately after taking the PAXLOVID. I didn't test negative until around 2 or 3 days after finishing the PAXLOVID.
4/3 = SATURDAY - 12:30 AM ,  USED 2 ACETAMINOPHEN PM  ( This what i use nightly ) 6:30 AM ,  CHILLS (FEVER)  LASTED COUPLE OF HOURS TIRED NO ENERGY , NO FOOD UNTILL DINNER TIME , WAS TOLD I LOOKED PALE , ** THAT SATURDAY AFTERNOON I WAS SMELLING AN ODOR LIKE GARBAGE, WIFE SAID SHE DIDN'T SMELL ANYTHING, LASTED FOR A FEW HOURS.??? 4/4 = SUNDAY - STILL LOW ENERGY.  EVERY MORNING FOR PAST 20 YEARS I RINSE EYES WITH SALINE SOLUTION. I SKIPPED SATURDAY, TRIED SUNDAY & MY EYES STARTED BURNING, TRIED A DIFFERENT BOTTLE STILL BURNING, HAD TO STOP. 4/5 = MONDAY - FEELING BETTER & EYES RINSED WITH NO PROBLEM .???
VACCINATION WAS GIVEN 5 DAYS EARLY. DUE DATE FOR SECOND VACCINATION IS 3/30
pt administered on 22FEB93; mom phoned office 23FEB93 stated pt had temp of 106; APAP & sponge bath given in office w/immed dec in temp;
Began violently throwing up, could not keep water down, or any type of fluid or food. Vomited throughout the evening hours until he kept down 4oz of formula at 10:00 AM the following morning 10/29/16. Continued off and on vomiting throughout the day 10/29/16. Awoke 10/30/2016 covered in hives from head to toe. Seen by Pediatrician on 10/30/2016 recommended BENADRYL and/or CLARITIN to control the hives.
Couldn't hear well out of rt ear. At 0930 on 9/28/10, felt dizzy and stumbled a few times; every time turned head, dizziness worsened; nausea started at 11am on 9/28/10; felt dizzy throughout rest of day. ON 9/29/2010, still a little dizzy, but 80-90% better.
horse raspy voice; sore throat; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and DYSPHONIA (horse raspy voice) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 30-May-2021, the patient experienced DYSPHONIA (horse raspy voice). At the time of the report, OROPHARYNGEAL PAIN (sore throat) and DYSPHONIA (horse raspy voice) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
pt recv vax on 24JUL-pronounced dead @ hosp on 26JUL;
This spontaneous report was received from a registered nurse referring to an unspecified number of patients of unspecified demographics. The nurse reported that, the patients received improperly stored doses of VARIVAX administered subcutaneously on 01-MAR-2017 (lot number M027344, expiration date 01-JUN-2018, dose was not reported) and on 07-MAR-2017 (lot number M033906, expiration date 20-JUL-2018, dose was not reported). No adverse events were reported. The doses of vaccine experienced a temperature excursion of 61F and 47F to 77F for 27.5 hours which was detected by a digital data logger. There was no previous excursion reported. No product quality complaint (PQC) was reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA004285.
This spontaneous report as received from a health professional refers to a 12 month old (also reported as less than 1 year old) female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 25-JAN-2018, the patient was vaccinated with PNEUMOVAX 23 first dose, lot # N019348, expiration date 08-FEB-2019, in the left vastus, intramuscularly (dose was not reported) for prophylaxis. On the same day, the patient was concomitantly vaccinated with FLUZONE, M-M-R II, VARIVAX and VAQTA. The patient received PNEUMOVAX 23 instead of Pneumococcal conjugate vaccine (PCVB). The patient was called back to office for observation. No adverse event was observed, however the outcome of adverse event was also reported as recovered.
Case number PHEH2012US013857 is an initial spontaneous report received from a nurse on 10 Jul 2012 with a follow-up received on 26 Jul 2012. This case refers to an 18-year-old female patient. She was vaccinated with MENVEO vaccine (batch number: M10135B) intramuscularly into the left arm on 28 Jun 2012. The nurse stated that this patient was administered only MenCWY liquid conjugate component, instead of being reconstituted with MenA component. No adverse event occurred following vaccination. Follow-up received from the nurse on 26 Jul 2012: Updated patient demographics.
He is very swollen by his left armpit towards the inside of his chest.; This is a spontaneous report from a contactable consumer. This 16-year-old male consumer (patient) reported for himself that he received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 12Aug2021 as SINGLE DOSE for covid-19 immunisation. The patient's medical history was none. Concomitant medication included Meloxicam. Patient was very swollen by his left armpit towards the inside of his chest. Prior to vaccination and since the vaccination, the patient has not been tested for COVID-19. No covid prior vaccination and post vaccination. The patient has not received any treatment. The outcome of the event was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I had pain at the beginning, then with rash after that itching, I still have itching right now. I went to see my doctor, he asked me to use hydrocortisone cream, but the itching will not go away.
Red swollen area that showed up 2 days after injection - patient states warm to the touch and painful. Told patient to keep eye on it, if it grows or she gets a fever to go to Doctor.
Per the NP:   1:20pm: While in observation, patient had an episode of syncope/ hypotension. It was unclear at the time if this was a reaction to the vaccination or not.  Was treated immediately by NP and EMT/Paramedic staff.  911 was called and pt  was transferred to the ER via monitored stretcher for further evaluation. Prior to leaving, and as pt was being transferred from one stretcher to the transport stretcher, pt experienced another syncopal episode.   No arrhythmia noted on monitor, BP running 70's/50's. Awake, sluggish but oriented to person and place upon leaving.  Transported via monitored stretcher to the ER.
1 VIAL OF JANSSEN COVID-19 VACCINE WAS DILUTED WITH 1.8 ML OF SALINE AND A SINGLE DOSE GIVEN BY MISTAKE; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's history of drug abuse or illicit drug usage, consume alcohol, and smoking was not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced 1 vial of janssen covid-19 vaccine was diluted with 1.8 ml of saline and a single dose given by mistake. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of 1 vial of janssen covid-19 vaccine was diluted with 1.8 ml of saline and a single dose given by mistake was not reported. This report was non-serious.
Information has been received from a certified medical assistant concerning a 63 year old female smoker with allergic to codeine, gastrointestinal problems, and benign adrenal adenoma who on 05-MAY-2011 was vaccinated SC with a 0.5 ml dose of ZOSTAVAX (Merck) (Lot number: 670384/0253AA; Expiration date: 18-MAY-2012) in left upper arm. Concomitant therapy included simvastatin (manufacturer unknown). Subsequently the patient developed an injection site reaction following vaccination with ZOSTAVAX (Merck). The injection site reaction was described as a red, swollen, itchy (no rash) lump at the injection site. It was not clear at the time of the call when the injection site reaction started. The patient called the office on 09-MAY-2011 to report the injection site reaction and that the swelling and redness was diminishing. The injection site reaction (red, swollen, itchy (no rash) lump) was reported to have resolved after a week to 10 days, but currently there was a dark brown discoloration where the injection site reaction was. The dark brown discoloration was described as 10 to 12 cm in length and 7 to 8 cm in width. The patient called the office and was not given treatment. No lab diagnostics study was performed. At the time of the report, the patient's dark brown discoloration was not recovered. Additional information has been requested.
In November of 1999, the pt developed a "full-blown case of chickenpox." The pt sought unspecified medical attention. Subsequently the pt recovered.
dizziness, light headed, nausea with 5 minutes of vaccination  treatment: water, food, antihistamine
The patient had just finished receiving vaccines for her 15 year old school physical exam. Patient received HPV #2, Hep A #2, Varicella #2 and TBN. Pt. stated she had not eaten breakfast prior to appointment. Approximately 30 seconds following vaccine administration, patient's eyes were rolling, twitching her eyeballs and had urinary incontinence. Pt's vitals were stable, 911 was called. After approximately 1 1/2 minutes patient was alert & oriented. Patient taken to ED for evaluation.
I got my period early (21 days versus 26 day average cycle) and had for 18 days (versus average 5 days)
Suffered extreme joint pain in left knee beginning Monday 8/30/21.  Vaccine was given very high in arm, maybe in bursa.
I experienced sudden onset of two types of arrhythmias and my regular tachycardia; atrial flutter, atrial fib, and SVT. Extremely regularly irregular. A colleague called 911. The paramedic put an EKG on me. They decided to fly me off (via med vac, since I live on an island). On the way to the heli pad, the paramedic administered 5 mg of metoprolol and in 2-3 mins the arrhythmia resolved; about 20-25 min duration in all. However on advice of the physician, they flew me to Bellingham where I stayed for 2 hours. The physician on call was fairly uninformative and I left after 2 hours.  This was not supraventricular tachycardia. I have never had this type of arrhythmia before.
After being observed for approximately 20 minutes and patient walked to her car without assistance I was called to assess the patient in the parking lot for troubles breathing.  EMS was called as I made my way outside.  Upon my arrival patient was leaning out of the car and stating that she could not breath.  She was able to tell me that she was allergic to penicillin.  Oxygen was immediately placed on the patient with minimal relief.  Lung sounds were coarse throughout.  She then  began to vomit about every 20-30 seconds.  Epipen was administered in the right leg with no relief.  Patient continued to complain of troubles breathing and vomiting.  A second epipen was administered in the patients right arm again with no relief.  A few minutes later patient was given racemic epinephrine through the oxygen mask.  There appeared to be mild improvement in her breathing as she appeared more comfortable, but still complaining of shortness of breath and vomiting.  When EMS arrived patient was unable to transport herself to the stretcher.  When EMS and clinical staff transferred patient to the stretcher she became unresponsive.  She appeared to still be breathing.  She did not respond to verbal stimuli.  Per ED report large amount of fluid was suctioned from the patients lungs following intubation in the ambulance.  When patient arrived to the ED she was extubated and re-intubated without difficulty and further fluid was suctioned.  At that time patient was found to be in PEA, shock was delivered.  Shortly thereafter no cardiac activity was found and patient pronounced dead.
DRY COUGH; COLD; This spontaneous report received from a patient concerned a 49 year old White, Not Hispanic/Latino male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26. cov2. s (dose number in series 1) (suspension for injection, route of admin not reported and batch number: 1808609 and expiry: unknown) dose was not reported, 1 total, administered at right arm on 27-MAY-2021 for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (dose number in series 1). The patient received booster covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 211A21a and expiry: unknown) dose was not reported, 1 total, administered at right arm on 16-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in FEB-2022, the patient experienced dry cough and cold (all events with dose number in series 2). It was reported that patient had not been tested for covid, and suffering from cold for last week and thought dry cough was due to cold remnants but agent reporting any symptoms out of an abundance of caution. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dry cough and cold was not reported. This report was non-serious.
sleeplessness, extreme irritability, loss of appetite, very gassy recovered by 20NOV97;mild fever;
The night after my vaccination (3/17/21), 6hrs after my vaccination, I had chills, low grade fever, body aches, headache, fatigue, that lasted about 12hrs. Then I was fine after that. Then, on the evening of 3/22/21, I started getting those same symptoms but worse that the first time: 101.4 fever, chills, body aches, headache, fatigue, and also chest tightness and asthma, cough.
Disease varicella; (Varivax vaccine in 2000). 5 1/2 years later/break-through.
Cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Cough). At the time of the report, COUGH (Cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had been exposed to the virus.  No Concomitant medications were reported.  No Treatment information was reported..   Reporter did not allow further contact
CDC reports: 4 yo child developed fever to 105.4 & lasted for 3 days.
Pulmonary embolism. I experienced shortness of breath  and rapid heart rate a few days before my second dose. It worsened and I sought treatment  on 4/28/2021. I underwent pulmonary arteriogram with mechanical bilateral thromboaspiration to remove the clots and received blood thinners.
tested positive for COVID; He tested positive for COVID today.; This is a spontaneous report received from contactable consumer (patient). A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 30Mar2021 (Batch/Lot number: unknown) as dose 1, single and administration date 30Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient was 44-year-old at the time of vaccination. The patient had no relevant medical history. There were no concomitant medications. It was reported that the patient tested positive for COVID on 22Nov2021. The outcome of event was unknown.  The lot number for bnt162b2 was not provided and will be requested during follow up.
immunization sites red and swollen, taken to local Dr. office.  PA is following up with allergy testing. Since all 3 sites reacted the same he feels it may be a reaction to the metal of the needle possibly nickel
Crusted smallpox scar with satellite vesicles on erythemous base trunk (20).  Recrudescence Smallpox vaccination with eczema herpeticem.
This is my first pregnancy my son wasn't due until September 28th I was 32 weeks pregnant.
Right after shot: Blood clots on body, Bruising, red eye, rash, continued for months Also received a pfizer booster vaccine June 2022 and once again rashes blood clots bruising 3months after initial moderna vaccine Global transient amnesia and then a week later got Takaosubo (broken heart syndrome)
pt recvd vax & exp nausea, vomiting, abdo pain & flu like sx which appeared 1 day p/each dose; GI workup was neg; Hep B antibody was converted to pos;